Business Wire

REPLY

12.2.2024 09:31:34 CET | Business Wire | Press release

Share
REPLY: Concept Reply's Test Automation Framework Innovates the Monitoring of Electric Vehicle (EV) Charging Stations Through Artificial Intelligence and Machine Learning

Concept Reply, a company within the Reply Group specialising in IoT innovation, has expanded the capabilities of its Test Automation Framework to include the validation of electric vehicle charging systems. Using digital models (digital twins) integrated into the proprietary test cycle automation framework, Concept Reply's solution allows for the measurement of reliability, efficiency, and safety levels of charging stations by simulating complex scenarios in a controlled virtual environment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240212429452/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Reply's Global Test Automation Center is reshaping the landscape of EV charging testing with its end-to-end Test Automation Framework. Implemented at the Global Test Automation Center, Reply's laboratory specialising in the automation of product and service tests, the new Test Automation Framework for charging systems provides 360-degree monitoring of all touchpoints connected to the charging station. (Photo: Business Wire)

Implemented at the Global Test Automation Center, Reply's laboratory specialising in the automation of product and service tests, the new Test Automation Framework for charging systems provides 360-degree monitoring of all touchpoints connected to the charging station. This includes web portals, mobile applications, charging stations, and electric vehicle simulators. With the integration of artificial intelligence and machine learning, the framework not only implements standard end-to-end testing functions but also includes specific scenarios to verify interactions between various components and devices in a complex outdoor ecosystem managed by multiple entities.

The progressive transformation of the transport ecosystem towards smart mobility models and V2X scenarios is leading to a rapid increase in installed charging stations. This necessitates operators of sustainable mobility to provide services that are not only user-friendly but increasingly reliable and secure. In this scenario, digital competencies are crucial for managing both charging infrastructures and vehicles.

Reply supports companies involved in the entire new mobility supply chain by developing new application architectures to support the development of infrastructure and charging processes. This includes the creation of innovative systems enabling new models of energy flexibility, such as vehicle-to-home, vehicle-to-grid, microgrid, and energy community management.

Concept Reply's framework is designed to enable automakers, electric utility operators, and stakeholders to rigorously verify the compatibility of charging devices, both public and private, with various EV models and communication protocols. Through tests that assess performance on multiple levels, such as power, vehicle types, and environmental factors, the framework ensures continuity in interactions between vehicles and charging stations, ensuring quality services and reliability in the products offered.

To learn more about Test Automation Framework for Charging System Validation and Reply's quality engineering expertise, visit www.reply.com/en/quality-engineering.

Reply
Reply [EXM, STAR: REY] specialises in the design and implementation of solutions based on new communication channels and digital media. Reply is a network of highly specialised companies supporting key European industrial groups operating in the telecom and media, industry and services, banking, insurance and public administration sectors in the definition and development of business models enabled for the new paradigms of big data, cloud computing, digital media and the Internet of Things. Reply services include: Consulting, System Integration and Digital Services. www.reply.com

Concept Reply
Concept Reply specializes in the research, development, and validation of innovative solutions in the IoT (Internet of Things) field. Today, we are recognized as a center of expertise and excellence in Testing and Quality Assurance, and include a Business Unit that specializes in this service. Thanks to our laboratories and to an international team of professionals specializing in the QA and Validation fields, we are able to offer companies end-to-end support for the validation of products and services, while also optimizing costs and time-to-market. www.concept.reply.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240212429452/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release

Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye